HMGCS2 and hepatocellular carcinoma: Our previous study demonstrated that decreased HMGCS2 expression was correlated with the severity of HCC; however, whether HMGCS2 loss mediation of KB reduction alters the sensitivity of human HCC to sorafenib treatment remains unclear.